Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway
2017 · Journal of Pharmacological Sciences · 35 citations
https://doi.org/10.1016/j.jphs.2016.12.007
J
Jingfeng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
2.6K
Citations
23
h-index
34
i10-index
Jingfeng Li is an academic researcher from Changchun University of Chinese Medicine. The author has contributed to research in topics: RNA modifications and cancer & Chromosomal and Genetic Variations & CRISPR and Genetic Engineering. The author has an h-index of 23, co-authored 65 publications.
ORCID: 0009-0007-1671-8104Papers by this author
worksInsight into the binding of ACE-inhibitory peptides to angiotensin-converting enzyme: a molecular simulation
2018 · Molecular Simulation · 27 citations
https://doi.org/10.1080/08927022.2018.1557327
Protocol to differentiate glycosylphosphatidylinositol-anchored prion protein from pro-prion protein in cancer cells
2023 · STAR Protocols · 1 citations
https://doi.org/10.1016/j.xpro.2023.102298
Persistent ER stress causes GPI anchor deficit to convert a GPI-anchored prion protein into pro-PrP via the ATF6–miR449c-5p–PIGV axis
2023 · Journal of Biological Chemistry · 1 citations
https://doi.org/10.1016/j.jbc.2023.104982
Dauriporphine inhibited lung cancer cell viability, motility, and energy metabolism through the miR-424-5p/MAPK14 axis
2025 · Hereditas · 1 citations
https://doi.org/10.1186/s41065-025-00473-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat